Visalytics
Visalytics
approved EB-2 (NIW)

Associate Research Scholar

Molecular Genetics · Iran · 2025-04-02

Processing Time
147 days
Decision Date
2025-04-02
Location
Oklahoma
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in molecular genetics, specifically focusing on how noncoding RNA (ncRNA) molecules regulate gene expression and drive oncogenic behavior in brain tumors. Her work aims to develop RNA-based diagnostics and molecularly guided therapies for aggressive cancers like glioblastoma. This research bridges molecular biology and translational medicine to improve clinical outcomes through precision oncology.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's work in cancer epigenetics and therapeutic innovation was recognized for its national importance to U.S. healthcare.

2 Well-positioned to Advance the Endeavor Met

Her extensive publication record, citation count, and Ph.D. in molecular genetics demonstrate she is well-positioned to lead this research.

3 On Balance, Beneficial to Waive Job Offer Met

USCIS determined that her unique expertise in ncRNA and tumor progression justifies a waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on a distinguished record including 29 peer-reviewed journal articles, 3 abstracts, and 1 book chapter, which garnered 530 citations. Additionally, the petitioner completed 49 expert reviews and provided independent recommendation letters confirming her international reputation. Both EB-1A and NIW criteria were met, establishing her extraordinary ability and the national importance of her translational cancer research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions

Similar Cases

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Scientist

Biotechnology · Albania

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-10
The petitioner proposes to continue her research in molecular biology, specifically focusing on identifying drug targets and their mechanisms of action in complex biological samples. Her work utilizes proteogenomic approaches to elucidate the relationship between genetic mutations and protein functions in breast cancer. This research is intended to enhance the understanding of disease mechanisms and inform the development of targeted therapies for cancer, metabolic disorders, and neurodegenerative conditions.
View Case

Research Scientist

Healthcare · Vietnam

WeGreened EB-2 (NIW) rfe approved
297 days 2025-01-11
The petitioner proposes to continue her research in medical science by investigating molecular pathways involved in tumor proliferation. Her work focuses on developing targeted inhibitors and antibodies designed to slow or prevent cancer progression and improve patient monitoring in clinical settings.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Texas 106 days 2022-05-04
The petitioner proposes to continue her research in disease genetics and cellular therapeutics, specifically investigating stem cell-based cancer therapeutics and developing functional biomarkers for cancer treatment. Her work focuses on determining the mechanisms underpinning the development of cancer and neurodegenerative diseases to reduce their global impact.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 147 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist